Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome

NCT07328529 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Aggressive Behavior in Fragile X Syndome

Interventions

DRUG: SRX246
DRUG: Placebo

Sponsor

Azevan Pharmaceuticals

Collaborators

[object Object]